{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:09:37Z","timestamp":1772118577854,"version":"3.50.1"},"reference-count":133,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite much of the past 2\u00a0years being engulfed by the devastating consequences of the SAR\u2010CoV\u20102 pandemic, significant progress, even breathtaking, occurred in the field of chronic myeloid malignancies. Some of this was show\u2010cased at the 15th Post\u2010American Society of Hematology (ASH) and the 25th John Goldman workshops on myeloproliferative neoplasms (MPN) held on 9th\u201010th December 2020 and 7th\u201010th October 2021, respectively. The inaugural Post\u2010ASH MPN workshop was set out in 2006 by John Goldman (deceased) and Tariq Mughal to answer emerging translational hematology and therapeutics of patients with these malignancies. Rather than present a resume of the discussions, this perspective focuses on some of the pivotal translational hematology and therapeutic insights in these diseases.<\/jats:p>","DOI":"10.1002\/hon.2987","type":"journal-article","created":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T11:45:01Z","timestamp":1648986301000},"page":"491-504","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies"],"prefix":"10.1002","volume":"40","author":[{"given":"Tariq I.","family":"Mughal","sequence":"first","affiliation":[{"name":"Tufts University School of Medicine  Boston Massachusetts USA"},{"name":"University of Buckingham  Buckingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Pemmaraju","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center University of Texas  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Bejar","sequence":"additional","affiliation":[{"name":"University of California San Diego  La Jolla California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Gale","sequence":"additional","affiliation":[{"name":"Imperial College  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prithviraj","family":"Bose","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center University of Texas  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Jacques","family":"Kiladjian","sequence":"additional","affiliation":[{"name":"H\u00f4pital Saint\u2010Louis Universit\u00e9 de Paris Inserm  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Prchal","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Center  Salt Lake City Utah USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Royston","sequence":"additional","affiliation":[{"name":"John Radcliffe Hospital University of Oxford  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pollyea","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine  Aurora Colorado USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[{"name":"Medical University of Vienna  Vienna Austria"},{"name":"Ludwig Boltzmann Institute for Hematology and Oncology Medical University of Vienna  Vienna Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim H.","family":"Br\u00fcmmendorf","sequence":"additional","affiliation":[{"name":"University Hospital RWTH  Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Skorski","sequence":"additional","affiliation":[{"name":"Temple University Lewis Katz School of Medicine  Philadelphia Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinal","family":"Patnaik","sequence":"additional","affiliation":[{"name":"Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Santini","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliero Universitaria Careggi University of Florence  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[{"name":"Hospital St Louis Assistance Publique H\u00f4pitaux de Paris  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Kucine","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine  New York New York USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center University of Texas  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Mesa","sequence":"additional","affiliation":[{"name":"Mays Cancer Center UT Health San Antonio MD Anderson Cancer Center  San Antonio Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziano","family":"Barbui","sequence":"additional","affiliation":[{"name":"Fondazione per la Ricerca Ospedale Maggiore di Bergamo  Bergamo Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiseppe","family":"Saglio","sequence":"additional","affiliation":[{"name":"University of Turin  Turin Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Van Etten","sequence":"additional","affiliation":[{"name":"Chao Family Comprehensive Cancer Center University of California  Irvine California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-077958"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000516"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051113"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030270"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-695940"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.139337"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2622"},{"issue":"2","key":"e_1_2_7_11_1","article-title":"Driver mutation acquistion in utero and childhood followed by lifelong clonal evolution underlies myeloproliferative neoplasms","volume":"136","author":"Williams N","year":"2020","journal-title":"Blood"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17850"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110557"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0527-7"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0954-2"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-135872"},{"key":"e_1_2_7_17_1","first-page":"652","article-title":"Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies","volume":"38","author":"Mughal TI","year":"2021","journal-title":"Hematol Oncol"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(21)01815-2"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01070-8"},{"issue":"134","key":"e_1_2_7_20_1","first-page":"199","article-title":"Evaluation of tagraxofusp (SL\u2010401) alone and in combination with ruxolitinib for the treatment of myeloproliferative neoplasms","volume":"134","author":"Krishnan A","year":"2019","journal-title":"Blood"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815105"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(20)31008-9"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1433521"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04618-5"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637420"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-128422"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00995-y"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01405-z"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(21)01835-8"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137572"},{"key":"e_1_2_7_31_1","first-page":"9","article-title":"Addition of parsaclisib (INCB050465), a PI3K delta inhibitor, in patients with suboptimal response to ruxolitinib: a phase 2 study in patients with myelofibrosis","volume":"193","author":"Yacoub A","year":"2021","journal-title":"Br J Jaematol"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/ss00277-021-04683-w"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.242891"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01205-5"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1675879"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8899"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01111-2"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902328"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009984"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.012"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.04.004"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.04.004"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.45"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-142062"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1180"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5871-2"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0427-7"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0977-8"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.267252"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2021.01.002"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30121-6"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010568"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12634"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013343"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716614"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1008-z"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003988"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00710-0"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13968"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1969-6"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1201"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.189"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002379"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605949"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0463-7"},{"key":"e_1_2_7_67_1","article-title":"Eprenetapopt plus azacitidine in tp53\u2010mutated myelodysplastic syndromes and acute myeloid leukemia: a phase II study by the groupe francophone des myelodysplasies (GFM)","volume":"2021","author":"Cluzeau T","journal-title":"J Clin Oncol"},{"key":"e_1_2_7_68_1","article-title":"Eprenetapopt (APR\u2010246) and azacitidine in TP53\u2010mutant myelodysplastic syndromes","author":"Sallman DA","year":"2021","journal-title":"J Clin Oncol"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2020.101221"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01380"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006158"},{"key":"e_1_2_7_72_1","article-title":"Fitness landscape of clonal hematopoiesis under selective pressure of immune checkpoint blockade","volume":"4","author":"Miller PG","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002414"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24978"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120521"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012345"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16380"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143537"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071954"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28888"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2234"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.127"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao1690"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30166-8"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(02)00168-6"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01407.x"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-458521"},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062983"},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00640"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513098"},{"key":"e_1_2_7_91_1","article-title":"Avapritinib induces responses in patients with advanced systemic mastocytosis (advSM), regardless of prior midostaurin therapy [abstract]","volume":"4","author":"Gotlib J","year":"2020","journal-title":"Hemasphere"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2021.1959315"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137413"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0147"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14898"},{"key":"e_1_2_7_96_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.659253"},{"key":"e_1_2_7_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14604-6"},{"issue":"2","key":"e_1_2_7_98_1","first-page":"530","article-title":"Degradation of BRD4\u2010 a promising treatment approach not only for hematologic but also solid cancer","volume":"11","author":"Bauer K","year":"2021","journal-title":"Am J Cancer Res"},{"key":"e_1_2_7_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01350-x"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"e_1_2_7_101_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004856"},{"key":"e_1_2_7_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2021.101251"},{"key":"e_1_2_7_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003988"},{"key":"e_1_2_7_104_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0313"},{"key":"e_1_2_7_105_1","article-title":"Phenotype\u2010based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia","author":"Kuusanmaki H","year":"2019","journal-title":"Haematologica"},{"key":"e_1_2_7_106_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0710"},{"key":"e_1_2_7_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0233-1"},{"key":"e_1_2_7_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.10.005"},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-020-00126-z"},{"key":"e_1_2_7_110_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1240"},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/35077225"},{"key":"e_1_2_7_112_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-834895"},{"key":"e_1_2_7_113_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-466938"},{"key":"e_1_2_7_114_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-385658"},{"key":"e_1_2_7_115_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-784942"},{"key":"e_1_2_7_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.07.029"},{"key":"e_1_2_7_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.05.052"},{"key":"e_1_2_7_118_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010959107"},{"key":"e_1_2_7_119_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-050913-022545"},{"key":"e_1_2_7_120_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004638"},{"key":"e_1_2_7_121_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501072"},{"key":"e_1_2_7_122_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90825"},{"key":"e_1_2_7_123_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017006247"},{"key":"e_1_2_7_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.05.034"},{"key":"e_1_2_7_125_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-3761"},{"key":"e_1_2_7_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3181"},{"key":"e_1_2_7_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108221"},{"key":"e_1_2_7_128_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-638593"},{"key":"e_1_2_7_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1019"},{"key":"e_1_2_7_130_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26402"},{"key":"e_1_2_7_131_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V112.11.4763.4763"},{"key":"e_1_2_7_132_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010323"},{"issue":"1","key":"e_1_2_7_133_1","first-page":"11","article-title":"Phlebotomy\u2010induced iron deficiency increases the expression of prothrombotic genes","volume":"136","author":"Song J","journal-title":"Blood"},{"key":"e_1_2_7_134_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001379"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2987","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hon.2987","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T01:20:26Z","timestamp":1695864026000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1002\/hon.2987"],"URL":"https:\/\/doi.org\/10.1002\/hon.2987","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/HON.2987\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2987\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.2987\/v1\/decision1","asserted-by":"object"}]},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"2021-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}